CoreValve™ Evolut R™ FORWARD Study

CompletedOBSERVATIONAL
Enrollment

1,060

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 6, 2020

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Medtronic CoreValve™ Evolut R™ System

The Evolut R System is intended for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, to be at high or extreme risk for open heart surgery. The Evolut R TAV treats aortic stenosis by displacing and functionally replacing the dysfunctional native valve with a bioprosthetic valve delivered on a catheter while the heart is still beating, thus avoiding the risks of cardiopulmonary bypass. Its intended performance is to relieve aortic valve stenosis without inducing significant regurgitation, thereby restoring effective aortic valve function.

Trial Locations (54)

Unknown

Flinders Medical Centre, Adelaide

Monash Medical Centre, Melbourne

The Alfred Hospital, Melbourne

Fiona Stanley Hospital Perth, Perth

Universitair Ziekenhuis Antwerpen, Antwerp

London Health Sciences Centre - University Campus, London

Sunnybrook Health Sciences Center, Toronto

Saint Paul's Hospital, Vancouver

Angiografia de Occidente S.A., Santiago de Cali

Nemocnice Podlesi a.s., Třinec

Centre Hospitalier Universitaire - Hopital Henri Mondor, Créteil

Centre Hospitalier Regional Universitaire de Lille, Lille

Institut Hospitalier Jacques Cartier, Massy

Hopital Bichat - Claude Bernard, Paris

Clinique Pasteur, Toulouse

Herz- und Diabeteszentrum NRW - Ruhr-Universitaet Bochum, Bad Oeynhausen

Deutsches Herzzentrum Berlin, Berlin

University of Bonn, Cardiology, Bonn

Sana-Herzzentrum Cottbus GmbH, Cottbus

Herzzentrum Dresden GmbH Universitaetsklinik, Dresden

Universitaetsklinikum Düsseldorf, Düsseldorf

Elisabeth-Krankenhaus Essen GmbH, Essen

Universitätsklinikum Essen, Essen

University of Frankfurt, Frankfurt

Asklepios Klinik Sankt Georg, Hamburg

Städtisches Klinikum Karlsruhe GmbH, Karlsruhe

Herzzentrum Leipzig GmbH, Leipzig

Deutsches Herzzentrum Muenchen - Klinik an der TU Muenchen, Munich

Hygeia Hospital, Athens

Semmelweis Egyetem AOK, Budapest

Tel Aviv Sourasky Medical Center, Tel Aviv

Azienda Ospedaliera Spedali Civili di Brescia, Brescia

Presidio Ospedaliero Ferrarotto Alessi, Catania

IRCCS Policlinico San Donato, Milan

Ospedale San Raffaele - Milano, Milan

Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello, Pisa

Onze Lieve Vrouwe Gasthuis - Locatie Oosterpark, Amsterdam

Catharina Ziekenhuis, Eindhoven

St. Antonius Ziekenhuis, Nieuwegein

Erasmus Medisch Centrum, Rotterdam

Oslo Universitetssykehus-Ullevål Universitetssykehus, Oslo

Complejo Hospitalario Dr Arnulfo Arias Madrid, Panama City

Instytut Kardiologii, Warsaw

Centro Hospitalar de Vila Nova de Gaia/Espinho - Unidade I, Vila Nova de Gaia

Prince Sultan Cardiac Center, Riyadh

Mediclinic Panorama, Cape Town

Hospital Universitario Virgen de la Victoria, Málaga

Hospital Universitario Central de Asturias, Oviedo

Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela

Akademiska Sjukhuset, Uppsala

Royal Victoria Hospital - Belfast Health and Social Care Trust, Belfast

Royal Sussex County Hospital, Brighton

The Leeds Teaching Hospitals NHS Trust - Leeds General Infirmary, Leeds

The Royal Wolverhampton Hospitals NHS - New Cross Hospital, Wolverhampton

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT02592369 - CoreValve™ Evolut R™ FORWARD Study | Biotech Hunter | Biotech Hunter